{"pmid":32292814,"pmcid":"PMC7102578","title":"The SARS-CoV-2 outbreak from a one health perspective.","text":["The SARS-CoV-2 outbreak from a one health perspective.","The SARS-CoV-2 is a new human coronavirus candidate recently detected in China that is now reported in people on inhabited continents. The virus shares a high level of identity with some bat coronaviruses and is recognised as a potentially zoonotic virus. We are utilizing the One Health concept to understand the emergence of the virus, as well as to point to some possible control strategies that might reduce the spread of the virus across the globe; thus, containment of such virus would be possible.","One Health","Hemida, Maged Gomaa","Ba Abduallah, Mohammed M","32292814"],"abstract":["The SARS-CoV-2 is a new human coronavirus candidate recently detected in China that is now reported in people on inhabited continents. The virus shares a high level of identity with some bat coronaviruses and is recognised as a potentially zoonotic virus. We are utilizing the One Health concept to understand the emergence of the virus, as well as to point to some possible control strategies that might reduce the spread of the virus across the globe; thus, containment of such virus would be possible."],"journal":"One Health","authors":["Hemida, Maged Gomaa","Ba Abduallah, Mohammed M"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292814","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.onehlt.2020.100127","keywords":["Animal","Bats","CoVID-19","Coronavirus","MERS-CoV","One health","Outbreak","Reservoir","SARS-CoV","SARS-CoV-2"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295663656960,"score":8.233237,"similar":[{"pmid":32143990,"title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.","text":["The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.","The 2019-nCoV is officially called SARS-CoV-2 and the disease is named COVID-19. This viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those with an underlying chronic disease or immunosuppressed state. This is the third serious Coronavirus outbreak in less than 20 years, following SARS in 2002-2003 and MERS in 2012. While human strains of Coronavirus are associated with about 15% of cases of the common cold, the SARS-CoV-2 may present with varying degrees of severity, from flu-like symptoms to death. It is currently believed that this deadly Coronavirus strain originated from wild animals at the Huanan market in Wuhan, a city in Hubei province. Bats, snakes and pangolins have been cited as potential carriers based on the sequence homology of CoV isolated from these animals and the viral nucleic acids of the virus isolated from SARS-CoV-2 infected patients. Extreme quarantine measures, including sealing off large cities, closing borders and confining people to their homes, were instituted in January 2020 to prevent spread of the virus, but by that time much of the damage had been done, as human-human transmission became evident. While these quarantine measures are necessary and have prevented a historical disaster along the lines of the Spanish flu, earlier recognition and earlier implementation of quarantine measures may have been even more effective. Lessons learned from SARS resulted in faster determination of the nucleic acid sequence and a more robust quarantine strategy. However, it is clear that finding an effective antiviral and developing a vaccine are still significant challenges. The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally. Unfortunately, emergence of SARS-CoV-2 has led to numerous reports of Asians being subjected to racist behavior and hate crimes across the world.","J Autoimmun","Yang, Yongshi","Peng, Fujun","Wang, Runsheng","Guan, Kai","Jiang, Taijiao","Xu, Guogang","Sun, Jinlyu","Chang, Christopher","32143990"],"abstract":["The 2019-nCoV is officially called SARS-CoV-2 and the disease is named COVID-19. This viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those with an underlying chronic disease or immunosuppressed state. This is the third serious Coronavirus outbreak in less than 20 years, following SARS in 2002-2003 and MERS in 2012. While human strains of Coronavirus are associated with about 15% of cases of the common cold, the SARS-CoV-2 may present with varying degrees of severity, from flu-like symptoms to death. It is currently believed that this deadly Coronavirus strain originated from wild animals at the Huanan market in Wuhan, a city in Hubei province. Bats, snakes and pangolins have been cited as potential carriers based on the sequence homology of CoV isolated from these animals and the viral nucleic acids of the virus isolated from SARS-CoV-2 infected patients. Extreme quarantine measures, including sealing off large cities, closing borders and confining people to their homes, were instituted in January 2020 to prevent spread of the virus, but by that time much of the damage had been done, as human-human transmission became evident. While these quarantine measures are necessary and have prevented a historical disaster along the lines of the Spanish flu, earlier recognition and earlier implementation of quarantine measures may have been even more effective. Lessons learned from SARS resulted in faster determination of the nucleic acid sequence and a more robust quarantine strategy. However, it is clear that finding an effective antiviral and developing a vaccine are still significant challenges. The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally. Unfortunately, emergence of SARS-CoV-2 has led to numerous reports of Asians being subjected to racist behavior and hate crimes across the world."],"journal":"J Autoimmun","authors":["Yang, Yongshi","Peng, Fujun","Wang, Runsheng","Guan, Kai","Jiang, Taijiao","Xu, Guogang","Sun, Jinlyu","Chang, Christopher"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32143990","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.jaut.2020.102434","keywords":["Bats","Coronavirus","Epidemic","Epidemiology","Flu","Human to human transmission","Pandemic","Pneumonia","Pyroptosis","SARS-CoV","SARS-CoV-2"],"source":"PubMed","locations":["Spanish","Wuhan","China","Hubei","Asians","Huanan"],"countries":["Spain","China"],"countries_codes":["ESP|Spain","CHN|China"],"topics":["Diagnosis","Transmission","Prevention","Mechanism"],"weight":1,"_version_":1663352134174769153,"score":124.59643},{"pmid":32292881,"pmcid":"PMC7146059","title":"Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.","text":["Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.","Coronaviruses (CoVs) are a large family of enveloped, positive-strand RNA viruses. Four human CoVs (HCoVs), the non-severe acute respiratory syndrome (SARS)-like HCoVs (namely HCoV 229E, NL63, OC43, and HKU1), are globally endemic and account for a substantial fraction of upper respiratory tract infections. Non-SARS-like CoV can occasionally produce severe diseases in frail subjects but do not cause any major (fatal) epidemics. In contrast, SARS like CoVs (namely SARS-CoV and Middle-East respiratory syndrome coronavirus, MERS-CoV) can cause intense short-lived fatal outbreaks. The current epidemic caused by the highly contagious SARS-CoV-2 and its rapid spread globally is of major concern. There is scanty knowledge on the actual pandemic potential of this new SARS-like virus. It might be speculated that SARS-CoV-2 epidemic is grossly underdiagnosed and that the infection is silently spreading across the globe with two consequences: (i) clusters of severe infections among frail subjects could haphazardly occur linked to unrecognized index cases; (ii) the current epidemic could naturally fall into a low-level endemic phase when a significant number of subjects will have developed immunity. Understanding the role of paucisymptomatic subjects and stratifying patients according to the risk of developing severe clinical presentations is pivotal for implementing reasonable measures to contain the infection and to reduce its mortality. Whilst the future evolution of this epidemic remains unpredictable, classic public health strategies must follow rational patterns. The emergence of yet another global epidemic underscores the permanent challenges that infectious diseases pose and underscores the need for global cooperation and preparedness, even during inter-epidemic periods.","Cell Stress","Raoult, Didier","Zumla, Alimuddin","Locatelli, Franco","Ippolito, Giuseppe","Kroemer, Guido","32292881"],"abstract":["Coronaviruses (CoVs) are a large family of enveloped, positive-strand RNA viruses. Four human CoVs (HCoVs), the non-severe acute respiratory syndrome (SARS)-like HCoVs (namely HCoV 229E, NL63, OC43, and HKU1), are globally endemic and account for a substantial fraction of upper respiratory tract infections. Non-SARS-like CoV can occasionally produce severe diseases in frail subjects but do not cause any major (fatal) epidemics. In contrast, SARS like CoVs (namely SARS-CoV and Middle-East respiratory syndrome coronavirus, MERS-CoV) can cause intense short-lived fatal outbreaks. The current epidemic caused by the highly contagious SARS-CoV-2 and its rapid spread globally is of major concern. There is scanty knowledge on the actual pandemic potential of this new SARS-like virus. It might be speculated that SARS-CoV-2 epidemic is grossly underdiagnosed and that the infection is silently spreading across the globe with two consequences: (i) clusters of severe infections among frail subjects could haphazardly occur linked to unrecognized index cases; (ii) the current epidemic could naturally fall into a low-level endemic phase when a significant number of subjects will have developed immunity. Understanding the role of paucisymptomatic subjects and stratifying patients according to the risk of developing severe clinical presentations is pivotal for implementing reasonable measures to contain the infection and to reduce its mortality. Whilst the future evolution of this epidemic remains unpredictable, classic public health strategies must follow rational patterns. The emergence of yet another global epidemic underscores the permanent challenges that infectious diseases pose and underscores the need for global cooperation and preparedness, even during inter-epidemic periods."],"journal":"Cell Stress","authors":["Raoult, Didier","Zumla, Alimuddin","Locatelli, Franco","Ippolito, Giuseppe","Kroemer, Guido"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292881","week":"202016|Apr 13 - Apr 19","doi":"10.15698/cst2020.04.216","keywords":["COVID-19","Coronavirus","MERS-CoV","SARS-CoV","epidemiology","immunology","sARS-CoV-2"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1664266295738105857,"score":117.77691},{"pmid":32171952,"pmcid":"PMC7102543","title":"The SARS-CoV-2 outbreak: what we know.","text":["The SARS-CoV-2 outbreak: what we know.","There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus.","Int J Infect Dis","Wu, Di","Wu, Tiantian","Liu, Qun","Yang, Zhicong","32171952"],"abstract":["There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus."],"journal":"Int J Infect Dis","authors":["Wu, Di","Wu, Tiantian","Liu, Qun","Yang, Zhicong"],"date":"2020-03-16T11:00:00Z","year":2020,"_id":"32171952","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.ijid.2020.03.004","keywords":["Clinical features","CoVID-19","Diagnosis","Epidemiology","Managements strategies","SARS-CoV-2","Treatments","coronavirus"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1663352133934645249,"score":114.84475},{"pmid":32194253,"pmcid":"PMC7102648","title":"Molecular basis of COVID-19 relationships in different species: a one health perspective.","text":["Molecular basis of COVID-19 relationships in different species: a one health perspective.","Outside the Hubei province, China, the mild form of infection and the progressive recover of the COVID-19 patients suggest the intervention of \"unconventional\" biological mechanisms worthy of attention. Based on the high-homology between the Spike protein epitopes of taxonomically-related coronaviruses, we hypothesized that past contact with infected dogs shield humans against the circulating SARS-CoV-2. Elseways, the recurrent virus exposure over a short time-lapse might result in the Antibody Dependent Enhancement, triggering the violent immune reaction responsible for the severe clinical outcomes observed in the Hubei province. Nevertheless, further experimental studies are desired for a confidential evaluation of the postulated hypotheses.","Microbes Infect","Tilocca, Bruno","Soggiu, Alessio","Musella, Vincenzo","Britti, Domenico","Sanguinetti, Maurizio","Urbani, Andrea","Roncada, Paola","32194253"],"abstract":["Outside the Hubei province, China, the mild form of infection and the progressive recover of the COVID-19 patients suggest the intervention of \"unconventional\" biological mechanisms worthy of attention. Based on the high-homology between the Spike protein epitopes of taxonomically-related coronaviruses, we hypothesized that past contact with infected dogs shield humans against the circulating SARS-CoV-2. Elseways, the recurrent virus exposure over a short time-lapse might result in the Antibody Dependent Enhancement, triggering the violent immune reaction responsible for the severe clinical outcomes observed in the Hubei province. Nevertheless, further experimental studies are desired for a confidential evaluation of the postulated hypotheses."],"journal":"Microbes Infect","authors":["Tilocca, Bruno","Soggiu, Alessio","Musella, Vincenzo","Britti, Domenico","Sanguinetti, Maurizio","Urbani, Andrea","Roncada, Paola"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32194253","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.micinf.2020.03.002","keywords":["COVID-19","Canine respiratory coronavirus","Coronavirus","Immunization","One health","SARS-CoV-2"],"source":"PubMed","locations":["China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1663352133538283520,"score":107.20412},{"pmid":32247050,"pmcid":"PMC7118633","title":"Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.","text":["Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.","BACKGROUND: The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions. METHODS: Based on recently published literatures, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV) infection. RESULTS: The genome of 2019-nCoV partially resembled SARS-CoV and MERS-CoV, and indicating a bat origin. The COVID-19 generally had a high reproductive number, a long incubation period, a short serial interval and a low case fatality rate (much higher in patients with comorbidities) than SARS and MERS. Clinical presentation and pathology of COVID-19 greatly resembled SARS and MERS, with less upper respiratory and gastrointestinal symptoms, and more exudative lesions in post-mortems. Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible). CONCLUSION: The initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression.","Int J Infect Dis","Xie, Mingxuan","Chen, Qiong","32247050"],"abstract":["BACKGROUND: The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions. METHODS: Based on recently published literatures, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV) infection. RESULTS: The genome of 2019-nCoV partially resembled SARS-CoV and MERS-CoV, and indicating a bat origin. The COVID-19 generally had a high reproductive number, a long incubation period, a short serial interval and a low case fatality rate (much higher in patients with comorbidities) than SARS and MERS. Clinical presentation and pathology of COVID-19 greatly resembled SARS and MERS, with less upper respiratory and gastrointestinal symptoms, and more exudative lesions in post-mortems. Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible). CONCLUSION: The initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression."],"journal":"Int J Infect Dis","authors":["Xie, Mingxuan","Chen, Qiong"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32247050","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijid.2020.03.071","keywords":["2019-nCoV","COVID-19","MERS-CoV","SARS-CoV","SARS-CoV-2"],"source":"PubMed","topics":["Mechanism","Diagnosis","Treatment","Prevention"],"weight":1,"e_drugs":["tocilizumab","Chloroquine"],"_version_":1663352135814742016,"score":102.90453}]}